Carl A. Pelzel
Nessuna posizione attualmente
Profilo
Carl A.
Pelzel served as President & Chief Executive Officer at Assertio Therapeutics, Inc. from 2005 to 2011.
He also held the same position at Invenux, Inc. in 2001-2002.
Prior to that, he was SVP-Global Commercial Operations at Chiron Corp.
from 2003 to 2004.
Pelzel received his undergraduate degree from Hartwick College and his graduate degree from Université Paris 1 Panthéon-Sorbonne.
Precedenti posizioni note di Carl A. Pelzel
| Società | Posizione | Fine |
|---|---|---|
Assertio Therapeutics, Inc.
 Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Presidente | 04/04/2011 |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Direttore operativo | 01/09/2004 |
| Invenux, Inc. | Presidente | 01/11/2002 |
Formazione di Carl A. Pelzel
| Hartwick College | Undergraduate Degree |
| Université Paris 1 Panthéon-Sorbonne | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Assertio Therapeutics, Inc. engages in the manufacture and distribution of pharmaceutical products to treat pain and other central nervous system conditions. Its brands include Gralise, Zipsor, Lazanda, Cambia, NUCYNTA ER and NUCYNTA. The firm focuses on neurology, orphan and specialty medicines. The company was founded by John W. Shell on August 7, 1995 and is headquartered in Lake Forest, IL. | Health Technology |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
| Invenux, Inc. |
- Borsa valori
- Insiders
- Carl A. Pelzel
